Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-04-24 Tyree James L Director Grant or award +13,950 35,620
2015-03-02 GLAXOSMITHKLINE PLC 10% owner Purchase +92,674 $1,673,692.44 $155.1B 31,673,853
2015-02-20 Aguiar Michael W President & CEO Shares withheld for taxes −6,789 $18.22 $124K 458,107
2015-02-20 Aguiar Michael W President & CEO Shares withheld for taxes −6,789 $18.22 $124K 446,148
2015-01-07 WITEK THEODORE L JR Sr. VP, Corp Partnerships Grant or award +71,429 71,429
2015-01-07 WITEK THEODORE L JR Sr. VP, Corp Partnerships Grant or award +71,429 71,429
2015-01-07 ABERCROMBIE GEORGE B Sr. VP, Corp. Partnerships Grant or award +71,429 81,429
2015-01-07 Aguiar Michael W President & CEO Grant or award +176,056 464,896
2015-01-07 dEsparbes Eric SVP and CFO Grant or award +36,972 139,443
2014-12-22 Tyree James L Director Grant or award +6,500 21,670
2014-12-22 PEPE PAUL Director Grant or award +6,500 21,670
2014-12-22 WALTRIP WILLIAM H Director Grant or award +3,250 103,314
2014-12-22 FRIEDMAN CATHY Director Grant or award +6,500 21,670
2014-11-04 GLAXOSMITHKLINE PLC 10% owner Purchase +832,456 $12,786,524.16 $10644.2B 31,581,179
2014-10-30 Kearney Terrence C Director Grant or award +23,133 23,133
2014-10-16 dEsparbes Eric SVP and CFO Grant or award +102,471 102,471
2014-08-20 LEE JUNNING Sr. VP, Technical Operations Shares withheld for taxes −3,261 $22.76 $74K 262,198
2014-08-20 Mammen Mathai SVP, Research & Early Clin Dev Shares withheld for taxes −3,261 $22.76 $74K 334,040
2014-08-20 Shafer Bradford J Sr VP, Gen. Counsel, Secretary Shares withheld for taxes −3,261 $22.76 $74K 443,013
2014-08-20 BLUM LEONARD M Sr VP, Chief Comm. Officer Shares withheld for taxes −3,261 $22.76 $74K 401,538

Page 17 of 23 · 446 trades